Glenmede Trust’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Glenmede Trust’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-40,188	Closed	-$1.74M	–	2889
2015 Q3	$1.74M	Hold	40,188	–	–	0.01%	623
2015 Q2	$1.7M	Buy	40,188 +48	+0.1%	+$2.02K	0.01%	641
2015 Q1	$1.56M	Buy	40,140 +600	+2%	+$23.1K	0.01%	658
2014 Q4	$1.33M	Sell	39,540 -2,000	-5%	-$70.6K	0.01%	661
2014 Q3	$1.45M	Hold	41,540	–	–	0.01%	609
2014 Q2	$1.36M	Hold	41,540	–	–	0.01%	625
2014 Q1	$1.53M	Sell	41,540 -22,600	-35%	-$829K	0.01%	594
2013 Q4	$2.46M	Hold	64,140	–	–	0.03%	504
2013 Q3	$1.76M	Hold	64,140	–	–	0.02%	552
2013 Q2	$1.35M	Buy	+64,140	New	+$1.25M	0.02%	576

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Glenmede Trust's WX Position: Q4 2015 in Review

Glenmede Trust sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 40,188 shares — an estimated $1.74M sold.

Glenmede Trust first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $2.46M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Glenmede Trust reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Glenmede Trust sold 40,188 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1.74M.
Glenmede Trust first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
Glenmede Trust's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $2.46M in Q4 2013.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Glenmede Trust's 13F filing for Q4 2015, filed 11 Feb 2016.